3,4-(Methylenedioxy)phenylmagnesium bromide, 0.5M THF, 97.0%, 100ml

8-benzyl-4-(2-fluorobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-iodophenyl)propanoic acid, 98%, 100mg

Single-channel microliter pipette Pipetman® G, 1 to 10 µl, P10G, 1 piece

5-Bromo-4-chloro-2,6-dimethylpyrimidine, 95.0%, 1g

ETHYL 3-AMINO-1-BOC-AZETIDINE-3-CARBOXYLATE, 95.0%, 1g

Methyl 6-fluoro-3-oxo-2,3-dihydro-1H-indene-5-carboxylate, 95.0%, 5g

(R)-1-BOC-PIPERIDINE-3-CARBOXYLIC ACID HYDRAZIDE, 95.0%, 500mg

3-CHLORO-5-CYANOBENZYL ALCOHOL, 95.0%, 1g

3-chloro-N-(2-fluoro-5-methylphenyl)propanamide, 95.0%, 1g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-thioxanthen-2-ylcarbamate, 95.0%, 1g

2-Amino-5-bromo-4,6-dimethylpyridine, 95.0%, 1g

TEMPO, min. 98%, for synthesis, 1 g, glass packaging